Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 37.00 | |
10 mg | In stock | $ 50.00 | |
25 mg | In stock | $ 71.00 | |
50 mg | In stock | $ 95.00 | |
100 mg | In stock | $ 133.00 | |
500 mg | In stock | $ 336.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 46.00 |
Description | Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. |
Cell Research | Cells are plated into 48-well tissue culture plates (39,000 cells/mL) and allowed to grow for 48 h followed by treatment with vehicle or Tenofovir. Following the treatment period, cell viability is assessed using the MTT assay. The MTT assay relies on the conversion of tetrazolium dye 3-(4,5-dimethlthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan by NAD(P)H-dependent oxidoreductases[1]. |
Synonyms | PMPA, TDF, GS 1278 |
Molecular Weight | 287.21 |
Formula | C9H14N5O4P |
CAS No. | 147127-20-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4 mg/mL (13.92 mM), Heating is recommended.
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 2 mg/mL (6.96 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tenofovir 147127-20-6 Microbiology/Virology Proteases/Proteasome HBV Reverse Transcriptase HIV Protease inhibit Inhibitor PMPA TDF Human immunodeficiency virus GS-1278 HIV Hepatitis B virus GS1278 GS 1278 inhibitor